Opportunity ID: 353021

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-MH-25-120
Funding Opportunity Title: Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings (R34 Clinical Trial Required)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.242 — Mental Health Research Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 18, 2024
Last Updated Date: Mar 18, 2024
Original Closing Date for Applications: Jan 23, 2025
Current Closing Date for Applications: Jan 23, 2025
Archive Date: Feb 28, 2025
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
Independent school districts
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
State governments
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Special district governments
Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: NIMH seeks applications to evaluate the preliminary effectiveness of therapeutic and service delivery interventions that utilize lethal means safety strategies to reduce suicide risk in healthcare and community settings. Behavioral health clinics that incorporate lethal means counseling into their programming have been associated with significant reductions in suicide attempts and death. Yet, the field is lacking strong evidence on the effectiveness of these strategies tested in healthcare and community settings. Pilot effectiveness research will advance knowledge regarding optimization strategies, therapeutic change mechanisms, and inform decisions about whether further effectiveness testing is warranted. The research will provide preliminary evidence on the extent to which lethal means safety interventions more optimally lead to improved safety (e.g., number/percent of firearms safely stored, overdose injury codes for an individual) and lower suicide risk.
In this pilot phase of effectiveness research, the trial should be designed to evaluate the feasibility, tolerability, acceptability, safety, and potential effectiveness of the approach; to address whether the intervention engages the target(s)/mechanisms(s) that is/are presumed to underlie the intervention effects; and to obtain preliminary data needed as a pre-requisite to a larger-scale effectiveness trial (e.g., comparative effectiveness study, practical trial) designed to definitively test the effectiveness of the intervention.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-120.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 353021 Full Announcement-RFA-MH-25-120 -> RFA-MH-25-120-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or before January 24, 2025 PKG00285405 Jun 15, 2024 Jan 24, 2025 View

Package 1

Mandatory forms

353021 RR_SF424_5_0-5.0.pdf

353021 PHS398_CoverPageSupplement_5_0-5.0.pdf

353021 RR_OtherProjectInfo_1_4-1.4.pdf

353021 PerformanceSite_4_0-4.0.pdf

353021 RR_KeyPersonExpanded_4_0-4.0.pdf

353021 PHS398_ResearchPlan_5_0-5.0.pdf

353021 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

353021 RR_Budget_3_0-3.0.pdf

353021 RR_SubawardBudget30_3_0-3.0.pdf

353021 PHS398_ModularBudget_1_2-1.2.pdf

353021 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T08:59:18-05:00

Share This Post, Choose Your Platform!

About the Author: